Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma
Clinical trial NCT07299149 · RECRUITING
Trial details
- NCT number
- NCT07299149
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-25
- Primary completion
- 2028-04-28
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.